Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9023
|
pubmed:dateCreated |
1996-9-6
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
348
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8709722-Aged,
pubmed-meshheading:8709722-Analgesics, Non-Narcotic,
pubmed-meshheading:8709722-Clodronic Acid,
pubmed-meshheading:8709722-Humans,
pubmed-meshheading:8709722-Hypercalcemia,
pubmed-meshheading:8709722-Infusions, Parenteral,
pubmed-meshheading:8709722-Male,
pubmed-meshheading:8709722-Middle Aged
|
pubmed:year |
1996
|
pubmed:articleTitle |
Subcutaneous clodronate.
|
pubmed:publicationType |
Letter,
Case Reports
|